Clik here to view.
The Five Highest Growth Cardiovascular Procedures
#5. Cerebral thrombectomy. The initial use of cerebral thrombectomy systems has been a disappointment. It is generally assumed that the situation with end-user adoption is likely to improve...
View ArticleClik here to view.
Fixing congenital heart defects on a global scale
Congenital heart abnormalities – which occur in an estimated 1.1% to 1.3% of infants born in the U.S. and worldwide each year – constitute leading cause of birth defect-related deaths. To-date,...
View ArticleClik here to view.
Growth of Lower Extremity Angioplasty with Drug-Coated Balloons
The rationale for the development of drug-coated angioplasty balloons (DCBs) derives mainly from the limitations of drug-eluting stents (DES). Nonstent-based localized drug delivery using a DCB...
View ArticleClik here to view.
Eight Sectors of Cardiovascular Surgery Reveal Growth, Volume to 2022
The global market for cardiovascular devices is in the billions. Its size and association with life-saving clinical utility ensures that investors will support a surprisingly strong range of...
View ArticleClik here to view.
Medtech Fundings for September 2016
Fundings in medical technology stand at $813 million for the month, led by the $345 million private placement by Insulet Corp., followed by the $168 million funding of Intarcia Therapeutics and the...
View ArticleGlobal and Regional Cardiovascular Surgical and Interventional Procedures...
With few exceptions, cardiovascular technologies no longer command big premiums (like many other medtech sectors) and mature Western markets for cardio devices have already captured most of the...
View ArticleClik here to view.
Coronary and Peripheral Vascular Dominate Global Cardiovascular Procedure...
In 2016, the cumulative worldwide volume of the cardiovascular device procedures is projected to approach 15.05 million surgical and transcatheter interventions. This will include: roughly 4.73...
View ArticleClik here to view.
Coronary and venous interventions show inevitable Asia/Pacific dominance
Coronary revascularization, whether by bypass graft or percutaneous coronary intervention, drives an enormous amount of medtech business. Angioplasty catheters, guidewires, and the plethora of devices...
View ArticleClik here to view.
Cardiac Rhythm Disorders and Implantable, Device-based Treatments
Cardiac rhythm disorders, also called arrhythmias or dysrhythmias, encompass a variety of relatively common acute and chronic conditions characterized by recurrent distortions in the electrical and...
View ArticleClik here to view.
The Evolution of Coronary Revascularization Markets
Coronary artery bypass graft (CABG) procedure is the most common type of cardiovascular surgical intervention intended to “bypass” acute or chronic coronary artery obstructions via a newly created...
View ArticleClik here to view.
Cardiovascular Surgical and Interventional Procedures Worldwide, 2015-2022
In 2016, the cumulative worldwide volume of the the following CVD procedures is projected to approach 15.05 million surgical and transcatheter interventions: roughly 4.73 million coronary...
View ArticleClik here to view.
Peripheral Stenting Worldwide: Arterial, Venous, BMS, DES, AAA, TAA
First introduced about two decades ago as a bailout technique for suboptimal or failed iliac angioplasty, peripheral vascular stenting gradually emerged as a valuable and versatile tool for a variety...
View ArticleClik here to view.
Coronary revascularization options evolve
The number of options that are in use or development for coronary revascularization is extraordinary. Given the mortality associated with coronary artery disease, it is unsurprising that it has been...
View ArticleClik here to view.
Forgotten Opportunities: Early Stage Biotech and Medtech Investment
Due to the uncertainty in the development, clinical testing, and regulatory approval of both biotech and medical technologies, which increasingly have to be viewed with the same competitive lens,...
View ArticleClik here to view.
Interventional and Surgical Cardiovascular Procedure Volumes
Cardiovascular diseases (CVDs) are a variety of acute and chronic medical conditions associated with an inability of the cardiovascular system to sustain an adequate blood flow and supply of oxygen and...
View ArticleClik here to view.
Cardiovascular procedure volume growth (interventional and surgical)
Cardiovascular surgical and interventional procedures are performed to treat conditions causing inadequate blood flow and supply of oxygen and nutrients to organs and tissues of the body. These...
View ArticleAbdominal and thoracic aortic aneurysm repair: procedures forecast
Below is an excerpt from, “Global Dynamics of Surgical and Interventional Cardiovascular Procedures, 2015-2022,” (Report #C500 described, available online). Selection of specific management protocols...
View ArticleClik here to view.
The global dynamics of cardiovascular surgical and interventional procedures
This is an excerpt from Report #C500, “Cardiovascular Procedures to 2022.” Cardiovascular Procedures in 2016 • Coronary artery bypass graft (CABG) surgery; • Coronary angioplasty and stenting; • Lower...
View ArticleClik here to view.
Cardiovascular procedure volumes in the rest of the world
Cardiovascular procedures are high volume, big business in the well developed U.S, European, and Asia/Pacific markets. But much potential procedure volume has been tapped in these markets, with any...
View ArticleClik here to view.
The future of medicine in 2037
In the post below from 2016, we wrote of what we can expect for medicine 20 years into the future. We review and revise it anew here. An important determinant of “where medicine will be” in 2035 is the...
View Article
